Laverock Therapeutics
Developing disease-responsive advanced therapies through programmable gene control technology.
About
Technology stack
detected 2026-06-15No comments yet. Be the first to share your take.
What does Laverock Therapeutics do?
Laverock Therapeutics develops programmable advanced therapies that are disease-responsive, utilizing unique platform technologies for precise gene control. Their system enables therapies to act only where and when needed, with enhanced precision and improved safety profiles. They serve the biotechnology and pharmaceutical industries by transforming therapeutic and non-therapeutic applications through their modular technology platforms and advanced therapy pipeline.
How much funding has Laverock Therapeutics raised?
Laverock Therapeutics has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Laverock Therapeutics headquartered?
Laverock Therapeutics is headquartered in Cambridge, England, United Kingdom.
When was Laverock Therapeutics founded?
Laverock Therapeutics was founded in 2020.
What industry does Laverock Therapeutics operate in?
Laverock Therapeutics operates in Biotechnology, Gene Therapy, Drug Delivery, Healthcare, Biotech, MedTech.